The study, conducted by a team of researchers from Johnson and Johnson, looked at previous existing research, conducted between December 2019 and August 2020 for Covid and from January 2020 to June 2021 for Long Covid, that evaluated the effects of COVID-19 on 1.3 . million people.
The study, published in Current Medical Research and Opinion, is one of the first to assess the specific health problems associated with coronavirus-related illness by gender.
According to the study authors, “Knowledge about fundamental sex differences underlying the clinical manifestations, disease progression and health outcomes of Covid-19 is critical to the identification of effective therapies. Immune system differences between women and men may be an important driver of sex differences. in long Covid.”
“Women develop faster and more robust immune responses, which can protect them from the initial infection.
“However, this same difference can leave women vulnerable to long-term autoimmune diseases,” she added.